Skip to main content
[Preprint]. 2022 Oct 21:2022.10.20.22281265. [Version 1] doi: 10.1101/2022.10.20.22281265

Table 1.

Clinical and histopathological features of convalescent COVID-19 subjects and comparators.

Sub. Sex Patient type Histopathological Diagnosis Focus Scorea Fibrosis/Atrophy Other Features Oral Symptoms Oral Signs Ocular symptoms Ocular Signs COVID-19 Severity Biopsy Post COVID-19
1d F Conv. FLS with Mild Chronic Sialadenitis 0b N N N/A N NA Mild 8
2d F Conv. FLS with Mild Chronic Sialadenitis 1 Y Duct injury and dilatation Y Y N/A N/A Mild 0c
FLS with Mild-to- Moderate Chronic Sialadenitis 2 Y GC Y N N/A N/A 6
3d M Conv. FLS with Mild Chronic Sialadenitis 0b Y Inflamm. infiltrating acini Y N/A N/A N/A Mild-to-Moderate 13
4e F HV Mild Chronic Sialadenitis 0 N N N N Y Mild-to-Moderate 21
5e M HV FLS with Mild-to-Moderate Chronic Sialadenitis 2 N GC, granuloma N N N N Asymp. UNK
6e M HV FLS with Mild Chronic Sialadenitis 0b N Perivascular infiltrates Y N N Y Mild-to-Moderate 7
SjDe F SjD FLS with Mild-to- Moderate Chronic Sialadenitis 2 Y Y Y Y Y
CTLe F HV Normal Histology 0 N N N N N
a

The focus score (FS) is the number of inflammatory infiltrates of at least 50 cells present in 4 mm2 of salivary gland area.

b

The subjects has focal lymphocytic sialadenitis (FLS) but with less than 1 per 4 mm2 of tissue. P2 has 8 foci per 37 mm2 of tissue (FS: 0.9) and P6 has 5 foci per 25 mm2 (FS: 0.8), and thus are borderline. Subject 3 has 4 foci per ~47 mm2 (FS: 0.3).

c

The patient had a biopsy 5 days after first symptom of COVID-19. Patient 2 clinical D5 case was reported in Huang, Perez, et al., Nature Med. 2021 (ref).

d

The subjects were enrolled on 20-D-0094 and biopsied as convalescent subjects (Subjects 1–3).

e

The subjects were enrolled on 15-D-0051 as either affected subjects (“SjD”) or healthy volunteers (HV) (Subjects 4–6 and Ex: HV).

Age range of subjects and comparators was 19–42 years.

Abbreviations: F, female; M, male; Conv., convalescent; N, no; Y, yes; FLS, focal lymphocytic sialadenitis; GC, germinal center; UNK, unknown; SjD, Sjögren’s Disease; HV, healthy volunteer; CTL, control gland from healthy volunteer.